Who We Are
'Akrivia' Greek for 'precision', means we were born with the idea of Precision at heart and innovation is in our DNA
​
Founded by Dr Amit Gupta, in 2019, we are a diagnostic firm aiming to launch breakthrough next-generation diagnostic products that would change the current Generic Cancer Treatment approach and provide a truly tailored 'Precision medicine' approach based on Tumour Biology.
Mission
Next-Generation Cancer Diagnostics products that would be classed as Standard of Care in Cancer Diagnostics
​
Our Diagnostic Tests would help in
-
Reducing the Overtreatment of Cancer patients
-
Improving the Cancer treatment outcomes
-
Drive Tumour Biology-based Cancer Precision Medicine Approach that would improve the quality of Cancer Treatments for better response
​
​
​
​
Vision
At Akrivia, our vision is to help bring next-generation cancer diagnostic tests that drive cancer treatment strategies from the current one-size-fits-all approach to the precision medicine approach in its truest sense.
We aim to be a force in tailored therapeutics where we are able to say more clearly to patients, payers, and providers – ‘this drug is not for everyone, but it is for you'.
